Acta Med. 2003, 46: 147-151
Inhibition of Aromatic Amino Acid Decarboxylase by a Group of New Potential Nonsteroidal Anti-Inflammatory Drugs with Antileukotrienic Effects
Possible in vitro inhibition of aromatic amino acid decarboxylase (AAD, EC 4.1.1.28) by a group of phenylsulfonylbenzoic acid derivatives VÚFB 19363, 19369, 19370, 19371, and 19760 as new potential anti-inflammatory compounds was studied using the substrate L-tyrosine. Enzyme inhibition by 2.7x10–5 M concentration of compound VÚFB 19363 (Quinlukast) was 17 %, AAD inhibition at 3.75 x 10–5 M concentration of compounds VÚFB 19369, 19370, 19371, and 19760 ranged between 9–23 %. There were distinct differences between individual compounds. Evaluation of inhibition kinetics suggested full reversibility with VÚFB 19369 and the uncompetitive type of inhibition in the case of compound VÚFB 19363. Considering the anti-inflammatory activity of the compounds studied, the weak AAD inhibition found is rather favourable for their prospective pharmacological effect.
Keywords
Aromatic amino acid decarboxylase, Antileukotrienic drugs, NSAIDs, Phenylsulfanylbenzoic acid derivatives, Quinlukast, Potential drugs, Influence of drugs.
Funding
This work was supported by Research project LN00B125 of the Czech Ministry of Education.
References
Copyright
Published by the Karolinum Press. For permission to use please write to actamedica@lfhk.cuni.cz.
